Le cancer médullaire de la thyroïde ou, comment des marqueurs tumoraux et les outils de la génétique autorisent le déploiement de mesures préventives : Médecine préventive et cancer. (II. Dépistage et détection précoce) = Medullary thyroid cancerMEURISSE, N; DEFECHEREUX, Th; HAMOIR, E et al.RMLG. Revue médicale de Liège. 2003, Vol 58, Num 5, pp 346-350, issn 0370-629X, 5 p.Article

Prognostic variables and calcitonin in medullary thyroid cancerCLARK, Jonathan R; FRIDMAN, Tauba R; ODELL, Michael J et al.The Laryngoscope. 2005, Vol 115, Num 8, pp 1445-1450, issn 0023-852X, 6 p.Article

Familial non-medullary thyroid cancer: A matched-case control studyMAXWELL, Evelyn Linda; HALL, Francis T; FREEMAN, Jeremy L et al.The Laryngoscope. 2004, Vol 114, Num 12, pp 2182-2186, issn 0023-852X, 5 p.Article

ACR Appropriateness Criteria^® thyroid carcinomaSALAMA, Joseph K; GOLDEN, Daniel W; WORDEN, Francis et al.Oral oncology (1997). 2014, Vol 50, Num 6, pp 577-586, issn 1368-8375, 10 p.Article

Risk stratification in medullary thyroid cancer: Moving beyond static anatomic stagingTUTTLE, R. Michael; GANLY, I.Oral oncology (1997). 2013, Vol 49, Num 7, pp 695-701, issn 1368-8375, 7 p.Article

Re-operation for recurrent lymph node metastasis of medullary thyroid cancer : is it useful ?VRIENS, B; VAN HEE, R.Acta chirurgica Belgica. 2007, Num 3, pp 331-335, issn 0001-5458, 5 p.Article

Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendationKARGES, W; DRALLE, H; RAUE, F et al.Experimental and clinical endocrinology & diabetes. 2004, Vol 112, Num 1, pp 52-58, issn 0947-7349, 7 p.Article

Locoregional control in patients with palpable medullary thyroid cancer : Results of standardized compartment-oriented surgeryDE GROOT, Jan Willem B; LINKS, Thera P; SLUITER, Willem J et al.Head & neck. 2007, Vol 29, Num 9, pp 857-863, issn 1043-3074, 7 p.Article

Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer. DiscussionCOOK, Mackenzie R; JIE LUO; NDIAYE, Mary et al.The American journal of surgery. 2010, Vol 199, Num 3, pp 315-318, issn 0002-9610, 4 p.Article

Role of 18F-FDG-PET and PET/CT imaging in thyroid cancerNANNI, Cristina; RUBELLO, Domenico; FANTI, Stefano et al.Biomedicine & pharmacotherapy. 2006, Vol 60, Num 8, pp 409-413, issn 0753-3322, 5 p.Article

The role of combined imaging in metastatic medullary thyroid carcinoma: ¹¹¹I-DTPA-octreotide and ¹³¹I/¹²³I-MIBG as predictors for radionuclide therapyZAIRONG GAO; BIERSACK, Hans J; EZZIDDIN, Samer et al.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 11, pp 649-656, issn 0171-5216, 8 p.Article

Medical Management of Metastatic Medullary Thyroid CancerMAXWELL, Jessica E; SHERMAN, Scott K; O'DORISIO, Thomas M et al.Cancer. 2014, Vol 120, Num 21, pp 3287-3301, issn 0008-543X, 15 p.Article

Medullary Thyroid Microcarcinoma: A Population-Level Analysis of 310 PatientsKAZAURE, Hadiza S; ROMAN, Sanziana A; SOSA, Julie A et al.Cancer. 2012, Vol 118, Num 3, pp 620-627, issn 0008-543X, 8 p.Article

Procalcitonin Levels Predict Clinical Course and Progression-Free Survival in Patients With Medullary Thyroid CancerWALTER, Martin A; MEIER, Christian; RADIMERSKI, Tanja et al.Cancer. 2010, Vol 116, Num 1, pp 31-40, issn 0008-543X, 10 p.Article

Segregation of the V804L mutation and S836S polymorphism of exon 14 of the RET gene in an extended kindred with familial medullary thyroid cancerPATOCS, A; VALKUSZ, Z; IGAZ, P et al.Clinical genetics. 2003, Vol 63, Num 3, pp 219-223, issn 0009-9163, 5 p.Article

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imagingPELLEGRITI, G; LEBOULLEUX, S; BAUDIN, E et al.British journal of cancer. 2003, Vol 88, Num 10, pp 1537-1542, issn 0007-0920, 6 p.Article

DIABETES INSIPIDUS AND PANHYPOPITUITARISM DUE TO INTRASELLAR METASTASIS FROM MEDULLARY THYROID CANCERSANTARPIA, Libero; GAGEL, Robert F; SHERMAN, Steven I et al.Head & neck. 2009, Vol 31, Num 3, pp 419-423, issn 1043-3074, 5 p.Article

RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical managementMUKHERJEE, S; ZAKALIK, D.Clinical genetics. 2011, Vol 79, Num 1, pp 1-16, issn 0009-9163, 16 p.Article

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management StrategiesGRANDE, Enrique; KREISSL, Michael C; FILETTI, Sebastiano et al.Advances in therapy. 2013, Vol 30, Num 11, pp 945-966, issn 0741-238X, 22 p.Article

Interplay between Ret and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid cancer cellsNICOLINI, Valentina; CASSINELLI, Giuliana; ZUNINO, Franco et al.Biochemical pharmacology. 2011, Vol 82, Num 7, pp 778-788, issn 0006-2952, 11 p.Article

Medullary thyroid carcinoma : Pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to ret proto-oncogene mutationsCHANG, Tien-Chun; WU, Shih-Lu; HSIAO, Yung-Lien et al.Acta cytologica. 2005, Vol 49, Num 5, pp 477-482, issn 0001-5547, 6 p.Article

Expression of the Active Notch1 Decreases MTC Tumor Growth In VivoJASKULA-SZTUL, Renata; PISARNTURAKIT, Pongthep; LANDOWSKI, Michael et al.The Journal of surgical research (Print). 2011, Vol 171, Num 1, pp 23-27, issn 0022-4804, 5 p.Article

Toxicity and Efficacy of Combined Radioimmunotherapy and Bevacizumab in a Mouse Model of Medullary Thyroid CarcinomaSALAUN, Pierre-Yves; BODET-MILIN, Caroline; FRAMPAS, Eric et al.Cancer. 2010, Vol 116, Num 4, pp 1053-1058, issn 0008-543X, 6 p., SUPConference Paper

Advances in the management of hereditary medullary thyroid cancerMACHENS, A; UKKAT, J; BRAUCKHOFF, M et al.Journal of internal medicine. 2005, Vol 257, Num 1, pp 50-59, issn 0954-6820, 10 p.Conference Paper

RET Gene Mutations (Genotype and Phenotype) of Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid CarcinomaKRAMPITZ, Geoffrey W; NORTON, Jeffrey A.Cancer. 2014, Vol 120, Num 13, pp 1920-1931, issn 0008-543X, 12 p.Article